Entera Bio Ltd. (ENTX) Earnings History
Net Loss11 years of earnings data (2015–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Entera Bio Ltd. (ENTX) Earnings Overview
As of June 22, 2026, Entera Bio Ltd. (ENTX) reported trailing twelve-month net income of -$12M, reflecting +0.0% year-over-year growth. The company earned $-0.26 per diluted share over the past four quarters, with a net profit margin of -27235.7%.
Looking at the long-term picture, ENTX's historical earnings data spans multiple years. The company achieved its highest annual net income of -$1M in fiscal 2016.
Entera Bio Ltd. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including ANIP ($90M net income, 8.9% margin), NKTR (-$158M net income, -297.1% margin), AMRN (-$34M net income, -18.2% margin), ENTX has room to improve margins relative to the peer group. Compare ENTX vs ANIP →
ENTX Earnings vs Peers
Earnings metrics vs comparable public companies
ENTX Historical Earnings Data (2015–2025)
11 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$11M | -19.9% | -$12M | $-0.25 | -27235.7% | -27450.0% |
| 2024 | -$10M | -7.3% | -$10M | $-0.25 | -5271.3% | -5295.6% |
| 2023 | -$9M | +32.0% | -$9M | $-0.31 | - | - |
| 2022 | -$13M | -7.3% | -$13M | $-0.45 | -9754.5% | -9752.2% |
| 2021 | -$12M | -8.7% | -$12M | $-0.47 | -2134.3% | -2139.6% |
| 2020 | -$11M | -3.9% | -$11M | $-0.54 | -3072.9% | -3059.7% |
| 2019 | -$11M | -4.8% | -$11M | $-0.90 | -4574.2% | -4853.4% |
| 2018 | -$10M | +8.0% | -$11M | $-1.29 | -2060.8% | -2172.2% |
| 2017 | -$11M | -833.9% | $11M | $-0.94 | - | - |
| 2016 | -$1M | +72.0% | -$5M | $-0.10 | - | - |
| 2015 | -$4M | - | -$4M | $-0.36 | - | - |
Download Data
Export ENTX earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
11+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
ENTX — Frequently Asked Questions
Quick answers to the most common questions about buying ENTX stock.
What is ENTX earnings per share (EPS)?
ENTX trailing twelve-month (TTM) diluted EPS is $-0.26, reflecting +0.0% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2015 to 2025 is available in the table on this page.
What is Entera Bio Ltd.'s net income?
Entera Bio Ltd. (ENTX) trailing twelve-month net income is $-12M as of 2025. Earnings declined +0.0% year-over-year.
Is ENTX profitable?
ENTX is not currently profitable on a TTM basis, reporting a net loss of $-12M. Net margin is -27235.7%. Investors should monitor for a return to profitability.
What is ENTX's earnings growth rate?
ENTX compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2015 to 2025.
What are ENTX's profit margins?
Entera Bio Ltd. net profit margin is -27235.7%, operating margin is -27450.0%, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -108.0%.
Is ENTX growing earnings?
ENTX TTM EPS: $-0.26. Net income: $-12M. YoY earnings change: +0.0%.
What was ENTX's best earnings year?
Entera Bio Ltd.'s highest annual net income on record is $-1M, achieved in fiscal year 2016. Earnings history on this page spans 2015 to 2025 and includes all annual and quarterly figures.
What were ENTX's earnings last quarter?
ENTX's most recent reported quarter was Q1 2026. Net income was $-4M with diluted EPS of $-0.07. For a full breakdown of all quarters, see the quarterly earnings table on this page.